New York Senate Bill S10465

New York 2025-2026 Regular Session

Caption

Relates to gender indication on insurance claim forms; provides policies shall not exclude coverage if gender indication is different from sex assigned at birth or gender otherwise recorded.

Summary

S10465 amends the New York Insurance Law to prohibit health insurers from denying coverage for otherwise covered screening, diagnosis, or treatment services solely because the gender listed on a claim form does not match the insured’s sex assigned at birth, gender otherwise recorded, or the gender typically associated with the service being billed. The bill applies this rule to individual, group, and nonprofit health insurance coverage provisions in the Insurance Law. The measure also makes clear that insurers may still take reasonable steps to verify eligibility, request additional information, investigate potential fraud, and assess clinical appropriateness. In effect, the bill is aimed at preventing administrative claim-form gender mismatches from being used as a basis to exclude medically covered services, while preserving standard utilization review and fraud-prevention tools.

Impact

If enacted, the bill would amend three sections of the Insurance Law—sections 3216, 3221, and 4303—to bar coverage denials based solely on gender indication on claim forms. It would affect insurers issuing or renewing hospital, surgical, or medical coverage in New York, and would apply prospectively to policies and contracts issued, renewed, modified, altered, or amended on or after the effective date. The practical impact would be to reduce claim denials tied to gender-marker mismatches and to strengthen access to medically necessary care, including for transgender and gender-diverse insureds and for services that are not limited by sex or gender identity.

Sentiment

The bill’s framing suggests a generally supportive policy goal centered on nondiscrimination in health coverage and reducing administrative barriers to care. Because there are no recorded committee transcripts or votes in the provided materials, there is no direct evidence of formal support or opposition in debate. The bill’s text itself reflects a balanced approach by pairing the anti-denial rule with explicit insurer safeguards for eligibility review, fraud detection, and clinical appropriateness.

Contention

The main potential point of contention is whether insurers should be required to ignore gender markers on claim forms when determining coverage, and how to distinguish improper denials from legitimate medical-necessity or eligibility reviews. Supporters would likely emphasize fairness, access to care, and preventing denials caused by outdated or mismatched administrative data, while critics may focus on operational complexity, fraud concerns, or the need for insurers to verify that a billed service matches the covered benefit. The bill addresses some of these concerns by expressly preserving the insurer’s ability to request additional information and review claims for fraud or clinical appropriateness.